Literature DB >> 12033745

Bone mineral density in adolescent girls with anorexia nervosa--a cross-sectional study.

G Jagielska1, T Wolanczyk, J Komender, C Tomaszewicz-Libudzic, J Przedlacki, K Ostrowski.   

Abstract

UNLABELLED: The total body and lumbar spine bone mineral density (BMD) were measured in order to determine the prevalence and possible risk factors of decreased BMD in anorexia nervosa (AN).
SUBJECTS: Sixty-one in-patient girls with DSM III-R AN: age 14.7+/-2.16 years; duration of AN 12.9+/-15.1 months; percentage of ideal body weight 70+/-8.7%; body mass index score -1.62+/-0.79.
METHOD: Total body (in 61 patients) and lumbar spine BMD (in 43 patients), content of lean and fat tissue mass were measured by DXA during the first month of treatment.
RESULTS: Low total body BMD was found in 23.7% and low lumbar spine BMD in 36.6% of patients. There was a negative correlation between BMD and age, age of menarche, degree of undernourishment, duration of AN and amenorrhea. A step-wise linear regression analysis revealed that age of menarche was the most important factor related to BMD in this group.

Entities:  

Mesh:

Year:  2002        PMID: 12033745     DOI: 10.1007/s007870200011

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  10 in total

1.  Skeletal outcomes by peripheral quantitative computed tomography and dual-energy X-ray absorptiometry in adolescent girls with anorexia nervosa.

Authors:  A D DiVasta; H A Feldman; J M O'Donnell; J Long; M B Leonard; C M Gordon
Journal:  Osteoporos Int       Date:  2016-07-08       Impact factor: 4.507

Review 2.  State of the art systematic review of bone disease in anorexia nervosa.

Authors:  Madhusmita Misra; Neville H Golden; Debra K Katzman
Journal:  Int J Eat Disord       Date:  2015-08-27       Impact factor: 4.861

Review 3.  Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities.

Authors:  D J Howgate; S M Graham; A Leonidou; N Korres; E Tsiridis; E Tsapakis
Journal:  Osteoporos Int       Date:  2012-08-09       Impact factor: 4.507

Review 4.  Anorexia Nervosa and Its Associated Endocrinopathy in Young People.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Horm Res Paediatr       Date:  2016-02-11       Impact factor: 2.852

5.  Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa.

Authors:  Vibha Singhal; Supritha Nimmala; Meghan Slattery; Kamryn T Eddy; Karen K Miller; Anne Klibanski; Madhusmita Misra
Journal:  Nutrients       Date:  2022-06-21       Impact factor: 6.706

6.  Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.

Authors:  M L Avila; E Pullenayegum; S Williams; A Shammas; J Stimec; E Sochett; K Marr; L R Brandão
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

Review 7.  Anorexia nervosa and bone.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  J Endocrinol       Date:  2014-06       Impact factor: 4.286

8.  Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II.

Authors:  Madhusmita Misra; Rajani Prabhakaran; Karen K Miller; Mark A Goldstein; Diane Mickley; Laura Clauss; Patrice Lockhart; Jennalee Cord; David B Herzog; Debra K Katzman; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

9.  Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1.

Authors:  Madhusmita Misra; Rajani Prabhakaran; Karen K Miller; Mark A Goldstein; Diane Mickley; Laura Clauss; Patrice Lockhart; Jennalee Cord; David B Herzog; Debra K Katzman; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

Review 10.  Anorexia nervosa and osteoporosis.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.